Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Non-cash Items (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Non-cash Items for 10 consecutive years, with $3.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items rose 31.9% to $3.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.0 million, a 31.9% increase, with the full-year FY2024 number at $2.9 million, up 39.24% from a year prior.
  • Non-cash Items was $3.0 million for Q3 2025 at Xtant Medical Holdings, roughly flat from $3.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $3.0 million in Q2 2025 to a low of $122614.0 in Q1 2021.
  • A 5-year average of $1.6 million and a median of $1.4 million in 2023 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: surged 447.6% in 2021, then grew 29.97% in 2025.
  • Xtant Medical Holdings' Non-cash Items stood at $649042.0 in 2021, then surged by 102.54% to $1.3 million in 2022, then surged by 61.04% to $2.1 million in 2023, then soared by 39.24% to $2.9 million in 2024, then increased by 1.98% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Non-cash Items are $3.0 million (Q3 2025), $3.0 million (Q2 2025), and $2.9 million (Q1 2025).